Chungnam National University Hospital
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1972-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cnuh.co.kr
Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
- Conditions
- HIV
- Interventions
- Drug: DTG + 3TC FDC
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06928090
- Locations
- 🇰🇷
Chungnam National University Hospital, 282 Munwha-ro, Daejeon, Korea, Republic of
A Comparative Analysis of Preoperative Liver Volumetry in Living Donor Liver Transplantation
Completed
- Conditions
- Living Donor Liver TransplantationLiver Failure
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 109
- Registration Number
- NCT06865612
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Recruiting
- Conditions
- GlioblastomaOrganoid
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06782984
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Chungnam, Korea, Republic of
Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups
Active, not recruiting
- Conditions
- Liver FailureLiving Donor Liver TransplantationBiliary ComplicationsBiliary Stents
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT06767553
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Tapering Heart Failure Medication in Patients with Heart Failure with Recovered Ejection Fraction; Open Label Prospective Random Trial
Not Applicable
Not yet recruiting
- Conditions
- Heart FailureEjection FractionRecovery of Function
- Interventions
- Drug: Beta blocker tapering out
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06724653
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Recruiting
- Conditions
- Autoimmune HepatitisNon-Alcoholic Fatty Liver DiseaseLiver AbscessPrimary Biliary CirrhosisPrimary Sclerosing Cholangitis
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT06519162
- Locations
- 🇰🇷
Chungnam National University Hospita, Daejeon, Jung-gu, Korea, Republic of
The Effect of Probiotics ATG-F4 in Cancer Patients
Phase 2
Recruiting
- Conditions
- Pancreatic CancerColon Cancer
- Interventions
- Drug: LT-002 (Lactobacillus reuteri ATG-F4
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06436976
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients
Not Applicable
Recruiting
- Conditions
- Sarcopenia
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05884138
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
Prediction of Delayed Cognitive Impairment in Cardiac Arrest Survivors With Good Neurological Outcomes
- Conditions
- Cardiac Arrest, Out-Of-HospitalCognitive Impairment
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05830422
- Locations
- 🇰🇷
박정수, Daejeon, Seo-gu, Korea, Republic of
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2
- Conditions
- Colon Cancer Stage III
- Interventions
- Drug: mFOLFIRINOXDrug: mFOLFOX 6
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Chungnam National University Hospital
- Target Recruit Count
- 308
- Registration Number
- NCT05179889
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of